Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

Psychiatric disorders encompass complex aberrations of cognition and affect and are among the most debilitating and poorly understood of any medical condition. Current treatments rely primarily on interventions that target brain function (drugs) or learning processes (psychotherapy). A mechanistic understanding of how these interventions mediate their therapeutic effects remains elusive. From the early 1990s, non-invasive functional neuroimaging, coupled with parallel developments in the cognitive neurosciences, seemed to signal a new era of neurobiologically grounded diagnosis and treatment in psychiatry. Yet, despite three decades of intense neuroimaging research, we still lack a neurobiological account for any psychiatric condition. Likewise, functional neuroimaging plays no role in clinical decision making. Here, we offer a critical commentary on this impasse and suggest how the field might fare better and deliver impactful neurobiological insights.

More information Original publication

DOI

10.1016/j.neuron.2022.07.005

Type

Journal article

Publication Date

2022-08-17T00:00:00+00:00

Volume

110

Pages

2524 - 2544

Total pages

20

Keywords

EEG, MEG, cognitive neuroscience, computational psychiatry, electroencephalography, fMRI, functional magnetic resonance imaging, magnetoencephalography, precision psychiatry, Brain, Electroencephalography, Functional Neuroimaging, Humans, Magnetic Resonance Imaging, Magnetoencephalography, Neuroimaging, Psychiatry